<DOC>
	<DOCNO>NCT00338104</DOCNO>
	<brief_summary>The primary objective study determine optimal dose glargine insulin convert intravenous short-acting continuous insulin infusion surgical intensive care unit patient use prospective , control , parallel group , randomize study design . Note : Lantus insulin proprietary name glargine insulin .</brief_summary>
	<brief_title>Conversion Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions Lantus Insulin</brief_title>
	<detailed_description>Critical illness cause impairment insulin secretion insulin action , result hyperglycemia even normal individual worsen hyperglycemia patient diabetes . Normalization elevate glucose level intensive insulin infusion therapy critically ill patient prove dramatically improve in-hospital mortality rate . After glucose level control insulin infusion , best way convert subcutaneous insulin regimen demonstrate conclusively insulin regimen best suit combination basal insulin glargine ( Lantus ) insulin premeal insulin bolus use short-acting insulin Lispro Aspart . Subjects randomize three group , 25 subject group , group differ accord start dose glargine insulin follow : 1 . Multiply total daily IV insulin dose , use final 6 hour infusion rate estimate total daily dose , 0.4 get start dose glargine , continue insulin drip 5 hour give glargine stop infusion ; 2 . Multiply total daily IV insulin dose , use final 6 hour infusion rate estimate total daily dose , 0.6 get start dose glargine , continue insulin drip 5 hour give glargine stop infusion ; 3 . Multiply total daily IV insulin dose , use final 6 hour infusion rate estimate total daily dose , 0.8 get start dose glargine , continue insulin drip 5 hour give glargine stop infusion . The glargine insulin continue basal insulin , adjust dos every 24 hour base fast blood glucose level . In addition , patient receive Lispro Aspart insulin prandial bolus insulin goal premeal 80 - 120 mg/dl , include bedtime . Glucose measurement obtain every 1- 4 hour patient insulin infusion , depend upon stability condition stability glucose level . Following transfer glargine insulin , glucose measure least four time per day , premeal bedtime per standard protocol hospital patient receive insulin . Glucose data obtain patient compare among various glargine regimen .</detailed_description>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Fasting glucose &gt; 100 mg/dl Patients surgical service intensive care unit receive intravenous insulin Inability obtain informed consent patient nextofkin Allergy insulin Participation another research study Patients `` donotresuscitate '' order</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>insulin</keyword>
	<keyword>glargine</keyword>
	<keyword>intravenous</keyword>
	<keyword>subcutaneous</keyword>
	<keyword>hospital</keyword>
	<keyword>diabetes</keyword>
	<keyword>glucose</keyword>
	<keyword>inpatient</keyword>
</DOC>